Chonbuk National University Hospital

Jeonju 561-712

0 studies enrolling now · 18 studies all time

What they study most

Acute Myeloid Leukemia, Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Atrial Fibrillation, Autism, Bipolar Depression, Carcinoma, Non-Small-Cell Lung, Chronic Obstructive Pulmonary Disease, Coronary Artery Disease, DLBCL, Diabetes Mellitus, Type 2, Diffuse Large B Cell Lymphoma, FL

Studies at this site

• First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma — Running, not enrolling
• Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer — Completed
• A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Completed
• Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients — Running, not enrolling
• Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2) — Completed
• Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8) — Completed
• Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides — Completed
• A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma — Completed
• Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy — Completed
• Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque — Completed
• A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer — Status unconfirmed
• A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia — Completed
• GLORIA-AF Registry Program - Second and Third Phases — Completed
• CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes — Completed
• Pediatric Open-Label Extension Study — Completed
• Real World Data on Gi(l)Otrif® Dose Adjustment — Completed
• Vadastuximab Talirine (SGN-CD33A; 33A) Combined With Azacitidine or Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia — Stopped early
• Pediatric Schizophrenia Efficacy and Safety Study — Completed